Page last updated: 2024-08-26

mci 9038 and warfarin

mci 9038 has been researched along with warfarin in 66 studies

Research

Studies (66)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (9.09)18.2507
2000's38 (57.58)29.6817
2010's19 (28.79)24.3611
2020's3 (4.55)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bai, T; Feng, Q; Guo, T; Jia, J; Li, X; Liu, Y; Pei, J; Song, Y; Wu, L; Wu, S; Zhang, Y; Zheng, X1
Loscalzo, J; Scharfstein, J1
Funahara, Y; Hijikata-Okunomiya, A; Opartkiattikul, N1
Fareed, J; Hoppensteadt, DA; Kahn, S1
Becker, JC; Hursting, MJ; Joffrion, JL; Knappenberger, GD; Schwarz, RP; Zehnder, JL1
Jang, IK; Januzzi, JL1
Armstrong, PW; Choy, JB1
Ataullakhanov, FI; Krasotkina, YV; Sinauridze, EI1
DiCicco, RA; Hursting, MJ; Jorkasky, DK; Montague, T; Sheth, SB1
Bode, C; Darius, H; Diehm, C; Encke, A; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schrör, T; Schulte, KL; Tebbe, U; Van Aken, H1
Cho, JH; Dan, T; Kim, HY; Koga, T; Koo, BA; Seo, HS; Yun, CH1
Gordan, L; Gorman, R; Kitchens, C; Zumberg, M1
Warkentin, TE3
Smythe, MA; Warkentin, TE1
Mattson, JC; Smythe, MA; Stephens, JL; Warkentin, TE; Zakalik, D1
Brown, PM; Hursting, MJ1
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R1
Fritsma, GA1
Shinohara, Y1
White, CM1
Bartholomew, JR1
Arpino, PA; Demirjian, Z; Van Cott, EM1
Hursting, MJ; Lewis, BE; Macfarlane, DE1
Bartholomew, JR; Hursting, MJ1
Rice, L1
Charest, AF; Geerts, WH; Grand'Maison, A1
Dager, W; Spinler, SA1
Aghababian, RV; Begelman, SM; Hursting, MJ; McCollum, D1
Kaneko, M; Kohno, H; Muraoka, M; Shikata, H1
Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL1
Durr, EA; Krueger, CD; Shapiro, NL1
Hirata, K; Iwanami, H; Odaka, M1
Kloecker, GH; Laber, DA; Martin, ME1
Ahmed, I; Majeed, A; Powell, R1
Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J1
Allen, SL; Barginear, MF; Bhaskaran, M; Bradley, T; Budman, DR; Donahue, L; Shapira, I1
Diez-Ewald, M1
Taimeh, Z; Weksler, B1
Chong, BH; Isaacs, A1
Maldonado, A1
Bara, C; Gras, C; Hafer, C; Haverich, A; Kuehn, C; Malehsa, D; Meyer, AL; Strüber, M1
Ichinoe, M; Mikami, T; Okayasu, I; Suzuki, K; Ujiie, S1
Ortel, TL1
Castellone, DD; Van Cott, EM1
Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D1
Jain, PG; Kauflin, MJ; Nanda, MM; Yannetta, JC1
Becher, T; Berdel, P; Braunstein, J; Gravius, S; Mayer, G; Müller, J; Oldenburg, J; Pötzsch, B; Rohrbach, F1
Young, G2
Austin, JH; Paciullo, CA; Stearns, CR; Winkler, AM1
Knovich, MA; Lesser, GJ; Strowd, RE1
Azuma, S; Lum, CJ1
Burger, CF; Schlesinger, JJ1
Fabris, F; Furian, L; Nordio, M; Treleani, M; Vianello, F1
Kadauke, S; Khor, B; Van Cott, EM1
Ito, S; McAlister, RK1
Gates, C; Neave, L; Scully, M1
Male, C; van Ommen, CH; Young, G1
Abramov, D; Birks, E; Bitar, A; Lenneman, A; Massey, T; Slaughter, M; Vijayakrishnan, R1
Boivin, G; Checkmahomed, L; Couture, C; Hamelin, MÈ; Jandrot-Perrus, M; Lê, BV; Venable, MC1
Curtis, BR; Erdil, RM; Gilyard, SN; Knelson, EH; Leaf, RK; Malhotra, R; Puram, RV; Ranganathan, R; Van Beuningen, AM; Wallwork, R; Weber, BN1
Chapman, K; Makhija, K; Prasad, R1

Reviews

24 review(s) available for mci 9038 and warfarin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
    European journal of medicinal chemistry, 2022, Jan-15, Volume: 228

    Topics: Fibrinolytic Agents; Humans; Molecular Structure; Thrombosis

2022
Molecular approaches to antithrombotic therapy.
    Hospital practice (Office ed.), 1992, May-15, Volume: 27, Issue:5

    Topics: Amino Acid Chloromethyl Ketones; Antithrombins; Arginine; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Protease Inhibitors; Sulfonamides; Thrombin; Warfarin

1992
Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Ancrod; Arginine; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Forecasting; Gangrene; Hemorrhage; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Platelet Aggregation; Protein C; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin

1999
Anticoagulant therapy in unstable angina.
    Cardiology clinics, 1999, Volume: 17, Issue:2

    Topics: Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Clinical Trials as Topic; Coronary Thrombosis; Disease Progression; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Hirudins; Humans; Myocardial Infarction; Peptide Fragments; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Warfarin

1999
Anticoagulation: the present and future.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2001, Volume: 7, Issue:3

    Topics: Administration, Oral; Amino Acid Chloromethyl Ketones; Anticoagulants; Arginine; Azetidines; Benzylamines; Binding Sites; Biological Availability; Blood Coagulation; Comorbidity; Coumarins; Drug Design; Embolism; Female; Forecasting; Glycine; Guanidines; Heart Diseases; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Neoplasms; Pipecolic Acids; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Safety; Serine; Stroke; Sulfonamides; Thrombin; Thrombophilia; Thrombosis

2001
Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Current opinion in pulmonary medicine, 2002, Volume: 8, Issue:5

    Topics: Anticoagulants; Antithrombins; Arginine; Autoimmune Diseases; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Warfarin

2002
Direct thrombin inhibitors.
    Clinical laboratory science : journal of the American Society for Medical Technology, 2004,Spring, Volume: 17, Issue:2

    Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombosis; Warfarin

2004
Heparin-induced thrombocytopenia: diagnosis and management.
    Circulation, 2004, Nov-02, Volume: 110, Issue:18

    Topics: Anticoagulants; Aortic Valve Insufficiency; Arginine; Autoantibodies; Autoimmune Diseases; Female; Fingers; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Ischemia; Middle Aged; Necrosis; Pipecolic Acids; Platelet Activation; Platelet Factor 4; Postoperative Complications; Raynaud Disease; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Toes; Warfarin

2004
[Clinical guidelines for stroke].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Nov-10, Volume: 93, Issue:11

    Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Radical Scavengers; Glycerol; Humans; Hyperlipidemias; Hypertension; Japan; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Sulfonamides; Thrombolytic Therapy; Time Factors; Warfarin

2004
Thrombin-directed inhibitors: pharmacology and clinical use.
    American heart journal, 2005, Volume: 149, Issue:1 Suppl

    Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Blood Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Warfarin

2005
Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Chest, 2005, Volume: 127, Issue:2 Suppl

    Topics: Administration, Oral; Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Factors; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Gangrene; Heparin; Heparitin Sulfate; Hirudins; Humans; Ischemia; Leg; Necrosis; Pipecolic Acids; Recombinant Proteins; Skin; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin

2005
Evolving management strategies for heparin-induced thrombocytopenia.
    Seminars in hematology, 2005, Volume: 42, Issue:3 Suppl 3

    Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin

2005
Anticoagulant use in patients with chronic renal impairment.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005, Volume: 5, Issue:5

    Topics: Anticoagulants; Arginine; Azetidines; Benzylamines; Fondaparinux; Heparin; Hirudins; Humans; Kidney Failure, Chronic; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Warfarin

2005
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
    Pharmacotherapy, 2006, Volume: 26, Issue:10

    Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin

2006
Argatroban for anticoagulation during cardiac surgery.
    European journal of haematology, 2007, Volume: 78, Issue:2

    Topics: Adult; Aged; Anticoagulants; Arginine; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Artery Bypass, Off-Pump; Drug Monitoring; Endocarditis, Bacterial; Female; Heart Valve Prosthesis Implantation; Heparin; Humans; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Middle Aged; Mitral Valve; Pipecolic Acids; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Subclavian Vein; Sulfonamides; Thrombosis; Venous Thrombosis; Warfarin; Whole Blood Coagulation Time

2007
Heparin induced thrombocytopenia: diagnosis and management update.
    Postgraduate medical journal, 2007, Volume: 83, Issue:983

    Topics: Anticoagulants; Arginine; Cardiovascular Surgical Procedures; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin

2007
Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2010, Volume: 16, Issue:1

    Topics: Anticoagulants; Arginine; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin

2010
Heparin-induced thrombocytopenia: what clinicians need to know.
    Thrombosis and haemostasis, 2009, Volume: 101, Issue:2

    Topics: Anticoagulants; Arginine; Autoantibodies; Chondroitin Sulfates; Dermatan Sulfate; Drug Monitoring; Fondaparinux; Heparin; Heparitin Sulfate; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin

2009
Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Anticoagulants; Arginine; Autoantibodies; Contraindications; Disseminated Intravascular Coagulation; Fondaparinux; Heparin; Hirudins; Humans; Pipecolic Acids; Platelet Count; Platelet Factor 4; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Thrombophilia; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin

2009
Laboratory monitoring of new anticoagulants.
    American journal of hematology, 2010, Volume: 85, Issue:3

    Topics: Anticoagulants; Arginine; Blood Coagulation; Blood Coagulation Tests; Chromogenic Compounds; Drug Monitoring; Factor Xa Inhibitors; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Warfarin

2010
Old and new antithrombotic drugs in neonates and infants.
    Seminars in fetal & neonatal medicine, 2011, Volume: 16, Issue:6

    Topics: Anticoagulants; Arginine; Fondaparinux; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infant; Infant, Newborn; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Venous Thromboembolism; Warfarin

2011
Anticoagulants in children and adolescents.
    Hematology. American Society of Hematology. Education Program, 2015, Volume: 2015

    Topics: Adolescent; Anticoagulants; Arginine; Child; Clinical Trials as Topic; Fondaparinux; Hematology; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombin; Thrombosis; Treatment Outcome; Warfarin

2015
How we manage patients with heparin induced thrombocytopenia.
    British journal of haematology, 2016, Volume: 174, Issue:1

    Topics: Anticoagulants; Arginine; Disease Management; Fondaparinux; Heparin; Humans; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia; Warfarin

2016

Trials

5 trial(s) available for mci 9038 and warfarin

ArticleYear
Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.
    Thrombosis and haemostasis, 2001, Volume: 85, Issue:3

    Topics: Adult; Anticoagulants; Arginine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor X; Hemostatics; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Thromboplastin; Warfarin

2001
Lack of pharmacokinetic interactions between argatroban and warfarin.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, Nov-01, Volume: 59, Issue:21

    Topics: Adult; Analysis of Variance; Anticoagulants; Area Under Curve; Arginine; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pipecolic Acids; Sulfonamides; Warfarin

2002
Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin.
    Pharmacotherapy, 2005, Volume: 25, Issue:2

    Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Chromogenic Compounds; Factor X; Female; Hospitals, University; Humans; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Predictive Value of Tests; Prospective Studies; ROC Curve; Sulfonamides; Warfarin

2005
Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2005, Volume: 11, Issue:3

    Topics: Anticoagulants; Arginine; Heparin; Humans; Infusions, Intravenous; International Normalized Ratio; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prospective Studies; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2005
Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
    Journal of thrombosis and thrombolysis, 2005, Volume: 19, Issue:3

    Topics: Adult; Aged; Amputation, Surgical; Arginine; Cause of Death; Female; Hemorrhage; Heparin; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Retrospective Studies; Risk Assessment; Sulfonamides; Survival Rate; Thrombocytopenia; Thrombosis; Treatment Outcome; Warfarin

2005

Other Studies

37 other study(ies) available for mci 9038 and warfarin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
An evaluation of prothrombin assay method using MD805 by means of warfarin-treated plasma.
    Thrombosis research, 1991, Dec-01, Volume: 64, Issue:5

    Topics: Adolescent; Adult; Antithrombins; Arginine; Benzamidines; Blood Coagulation Tests; Dipeptides; Guanidines; Humans; Pipecolic Acids; Prothrombin; Sulfonamides; Warfarin

1991
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs.
    Clinical chemistry, 1997, Volume: 43, Issue:9

    Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Blood Coagulation Factors; Blood Coagulation Tests; Drug Monitoring; Drug Therapy, Combination; Factor X; False Positive Reactions; Female; Heparin; Humans; Indicators and Reagents; Male; Pipecolic Acids; Prothrombin Time; Reference Values; Reproducibility of Results; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin

1997
The International Normalized Ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used.
    Clinical chemistry, 1999, Volume: 45, Issue:3

    Topics: Anticoagulants; Arginine; Humans; International Normalized Ratio; Pipecolic Acids; Prothrombin Time; Sulfonamides; Thromboplastin; Warfarin

1999
Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion.
    Biochimica et biophysica acta, 2000, May-01, Volume: 1474, Issue:3

    Topics: alpha-Macroglobulins; Antithrombins; Arginine; Blood Coagulation; Calcium; Coumarins; Diffusion; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Kinetics; Models, Theoretical; Pipecolic Acids; Plasma; Solutions; Sulfonamides; Thrombin

2000
The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:6

    Topics: Administration, Oral; Amidines; Animals; Arginine; Azepines; Bleeding Time; Carotid Artery Thrombosis; Dalteparin; Drug Evaluation, Preclinical; Fibrinolytic Agents; Hemorrhage; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Molecular Structure; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin; Vena Cava, Inferior; Venous Thrombosis; Warfarin

2001
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure.
    Thrombosis and haemostasis, 2001, Volume: 86, Issue:6

    Topics: Accidents, Home; Adult; Anticoagulants; Antithrombin III Deficiency; Arginine; Burns; Cardiovascular Agents; Coronary Vasospasm; Debridement; Drug Therapy, Combination; Explosions; Humans; Male; Pipecolic Acids; Sulfonamides; Ventricular Dysfunction, Left; Warfarin

2001
Comment: treatment of heparin-induced thrombocytopenia.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:9

    Topics: Anticoagulants; Arginine; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin; Thrombocytopenia; Warfarin

2002
Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.
    American journal of hematology, 2002, Volume: 71, Issue:1

    Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anticoagulants; Arginine; Autoimmune Diseases; Catheterization, Central Venous; Contraindications; Drug Administration Schedule; Drug Therapy, Combination; Female; Gangrene; Heparin; Hirudin Therapy; Hirudins; Humans; International Normalized Ratio; Leg; Male; Middle Aged; Necrosis; Pipecolic Acids; Protein C Deficiency; Recombinant Proteins; Sulfonamides; Surgical Wound Infection; Thrombin; Thrombocytopenia; Thrombophlebitis; Warfarin

2002
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
    The American journal of the medical sciences, 2002, Volume: 324, Issue:5

    Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin

2002
Comment: extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:11

    Topics: Aged; Anticoagulants; Arginine; Humans; International Normalized Ratio; Kidney; Kidney Function Tests; Liver; Lung Neoplasms; Partial Thromboplastin Time; Pipecolic Acids; Sulfonamides; Venous Thrombosis; Warfarin

2005
Heparin-induced thrombocytopenia from venous thromboembolism treatment.
    Journal of internal medicine, 2005, Volume: 258, Issue:6

    Topics: Amputation, Surgical; Anticoagulants; Arginine; Drug Administration Schedule; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome; Warfarin

2005
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8

    Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2006
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Pharmacotherapy, 2006, Volume: 26, Issue:12

    Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2006
[Bilateral cerebellar infarction caused by intracranial dissection of the vertebral artery after long periods of "Shiatsu"].
    No to shinkei = Brain and nerve, 2007, Volume: 59, Issue:2

    Topics: Acupressure; Acute Disease; Angiography; Anticoagulants; Arginine; Cerebellum; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Female; Humans; Infusions, Intravenous; Middle Aged; Pipecolic Acids; Sulfonamides; Tomography, X-Ray Computed; Vertebral Artery Dissection; Warfarin

2007
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    American journal of hematology, 2008, Volume: 83, Issue:3

    Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin

2008
Heparin-induced thrombocytopenia complicating hemodialysis.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2008, Volume: 14, Issue:1

    Topics: Adult; Anticoagulants; Arginine; Calciphylaxis; Drug Contamination; Female; Heparin; Humans; Necrosis; Pipecolic Acids; Renal Dialysis; Renal Insufficiency; Skin Diseases; Sulfonamides; Thrombocytopenia; Warfarin

2008
Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:1

    Topics: Acute Disease; Anticoagulants; Arginine; Blood Coagulation; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; International Normalized Ratio; Pipecolic Acids; Platelet Count; Polysaccharides; Recombinant Proteins; Research Design; Sulfonamides; Thrombin; Thrombocytopenia; Treatment Outcome; Venous Thrombosis; Warfarin

2008
[Are new anticoagulants better?].
    Investigacion clinica, 2007, Volume: 48, Issue:4

    Topics: Anticoagulants; Arginine; Drugs, Investigational; Factor Xa Inhibitors; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombin; Thrombosis; Warfarin

2007
Argatroban and catheter-directed thrombolysis with alteplase for limb- and graft-threatening thromboses in a patient with a history of HIT.
    American journal of hematology, 2009, Volume: 84, Issue:4

    Topics: Aged; Antibodies, Anticardiolipin; Anticoagulants; Arginine; Catheterization; Contraindications; Drug Therapy, Combination; Femoral Vein; Heparin; Humans; Iliac Vein; Infusions, Intravenous; Ischemia; Kidney; Kidney Transplantation; Male; Pipecolic Acids; Popliteal Vein; Postoperative Complications; Protein S Deficiency; Purpura, Thrombocytopenic, Idiopathic; Renal Veins; Sulfonamides; Thrombolytic Therapy; Thrombophilia; Tissue Plasminogen Activator; Vena Cava Filters; Venous Thrombosis; Warfarin

2009
HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
    The Annals of thoracic surgery, 2009, Volume: 88, Issue:2

    Topics: Anticoagulants; Arginine; Cardiopulmonary Bypass; Drug Therapy, Combination; Heart-Assist Devices; Heparin; Humans; Iloprost; Length of Stay; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Implantation; Sulfonamides; Thrombocytopenia; Warfarin

2009
Heparin-induced thrombocytopenia with multiple organized thrombi accompanied by unusual cholesterin deposition: autopsy case after long-term follow up.
    Pathology international, 2009, Volume: 59, Issue:10

    Topics: Aged; Anticoagulants; Arginine; Embolism, Cholesterol; Fatal Outcome; Heparin; Humans; Male; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin

2009
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.
    American journal of hematology, 2011, Volume: 86, Issue:2

    Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin

2011
Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:3

    Topics: Aged; Anticoagulants; Arginine; Atrial Fibrillation; Blood Coagulation Tests; Carotid Stenosis; Endarterectomy, Carotid; Female; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Warfarin

2011
Profiling of active thrombin in human blood by supramolecular complexes.
    Angewandte Chemie (International ed. in English), 2011, Jun-27, Volume: 50, Issue:27

    Topics: Aptamers, Nucleotide; Arginine; Binding Sites; Blood Coagulation; Coumarins; Enzyme Assays; Humans; Limit of Detection; Peptides; Pipecolic Acids; Sensitivity and Specificity; Sulfonamides; Thrombin

2011
Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
    Pharmacotherapy, 2012, Volume: 32, Issue:6

    Topics: Academic Medical Centers; Anticoagulants; Arginine; Blood Coagulation; Chromogenic Compounds; Databases, Factual; Drug Administration Schedule; Electronic Health Records; Factor X; Hospitals, Teaching; Humans; International Normalized Ratio; Male; Middle Aged; Pipecolic Acids; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sulfonamides; Warfarin

2012
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
    Current treatment options in oncology, 2012, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin

2012
A comparison of methods for estimating glomerular filtration rate for a population in Hawai'i with non-valvular atrial fibrillation.
    Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health, 2013, Volume: 72, Issue:9 Suppl 4

    Topics: Aged, 80 and over; Anticoagulants; Arginine; Asian People; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Glomerular Filtration Rate; Hawaii; Humans; Male; Morpholines; Pipecolic Acids; Retrospective Studies; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin

2013
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:2

    Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin

2014
Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
    Hematology (Amsterdam, Netherlands), 2015, Volume: 20, Issue:1

    Topics: Anticoagulants; Arginine; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Polycystic Kidney Diseases; Renal Dialysis; Sulfonamides; Thrombocytopenia; Warfarin

2015
Activated protein C resistance testing for factor V Leiden.
    American journal of hematology, 2014, Volume: 89, Issue:12

    Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin

2014
Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
    Pharmacotherapy, 2015, Volume: 35, Issue:7

    Topics: Anticoagulants; Antithrombins; Arginine; Carcinoma, Squamous Cell; Drug Substitution; Female; Heparin; Humans; International Normalized Ratio; Mandibular Neoplasms; Middle Aged; Mouth Mucosa; Pipecolic Acids; Prothrombin Time; Sulfonamides; Syndrome; Thrombocytopenia; Thrombosis; Treatment Failure; Warfarin

2015
Anticoagulation in children: Making the most of little patients and little evidence.
    Blood cells, molecules & diseases, 2017, Volume: 67

    Topics: Anticoagulants; Arginine; Blood Coagulation; Child; Drug Monitoring; Fondaparinux; Heparin; Hirudins; Humans; Peptide Fragments; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sulfonamides; Thrombosis; Venous Thromboembolism; Warfarin

2017
The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
    Artificial organs, 2017, Volume: 41, Issue:12

    Topics: Adult; Aged; Anticoagulants; Arginine; Eptifibatide; Female; Heart Failure; Heart-Assist Devices; Hemolysis; Heparin; Humans; Male; Middle Aged; Peptides; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Sulfonamides; Thrombosis; Warfarin; Young Adult

2017
Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in mice.
    The Journal of general virology, 2018, Volume: 99, Issue:10

    Topics: Animals; Anticoagulants; Arginine; Disease Models, Animal; Heparin; Metapneumovirus; Mice; Paramyxoviridae Infections; Pipecolic Acids; Sulfonamides; Survival Analysis; Treatment Outcome; Viral Load; Virus Replication; Warfarin

2018
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
    Thrombosis and haemostasis, 2020, Volume: 120, Issue:7

    Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Eptifibatide; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Stents; Sulfonamides; Thrombectomy; Thrombolytic Therapy; Thrombosis; Ticagrelor; Warfarin

2020
A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
    Pathology, 2021, Volume: 53, Issue:6

    Topics: Aged; Anticoagulants; Arginine; Heparin; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Sulfonamides; Thrombocytopenia; Warfarin

2021
chemdatabank.com